Glyphosate Task Force Urges Member States to Adopt a 15-Year Approval Period for Glyphosate
In advance of the Standing Committee meeting scheduled to take place on May 18th and 19th , the Glyphosate Task Force (GTF) underlines the importance of applying all elements of the EU legislative framework for the approval of active substances consistently and in full.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160512006361/en/
Based on the outcome of a comprehensive risk assessment, EU legislation provides for a 15-year approval period for authorised active substances.
The outcome of the EU evaluation of glyphosate concluded that it poses no unacceptable risks to human health or the environment. An unprecedented amount of data was assessed, including 353 new studies.
Mr Richard Garnett, Chairman of the GTF, said, “It is important that decisions regarding the length of approval periods granted to active substances are consistent. Any other approach would undermine the credibility of the renewal procedure.”
“Bearing in mind the conclusions reached by the BfR and EFSA, the GTF considers that a 15-year approval period for glyphosate is appropriate and should be granted, in line with EU legislation.”
“Glyphosate should not be treated any differently than other active substances which have received positive risk assessments from EFSA.”
Putting residue testing in context
A recent experiment conducted by a group of members of the European Parliament (MEPs) reportedly found that glyphosate residues were detected in urine samples. No information on the analytical methods applied to the testing has been made available. The scientific quality of the data produced therefore cannot be assessed or verified. In any case, the stated results of the testing quote residue levels which are the same as the recent Umwelt Bundesamt survey in Germany. These levels are within legally permissible limits and not considered to pose a risk to human health.
Official monitoring of pesticide residues conducted by EU Member States on an annual basis consistently demonstrates that in the vast majority of samples tested, residues are completely undetectable. In cases where residues are present, they are within legally permissible limits and well below a level which would pose a risk to human health.
Claire MacCarrick, +32 22 34 6860
41 Rue de la Science - 1040 Brussels
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
CA-TRADESHIFT19.10.2018 13:02 | pressemeddelelse
Tradeshift Announces Q3 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum